Coastlands Capital LP - 23 Feb 2026 SCHEDULE 13G Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

Filing Manager
Coastlands Capital LP
Reporting Manager
Coastlands Capital LP
Security
Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share
Symbol
KTTA
Shares outstanding
23,971,622 shares
Disclosed Ownership
2,394,765 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
27 Feb 2026, 16:01:28 UTC
Date of event
23 Feb 2026
SEC
View on sec.gov

Quoteable Key Fact

"Coastlands Capital LP disclosed 10% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 23 Feb 2026."

Quick Takeaways

  • Coastlands Capital LP filed SCHEDULE 13G for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
  • Disclosed ownership: 10%.
  • Date of event: 23 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 27 Feb 2026, 16:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Coastlands Capital LP 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital LLC
Coastlands Capital Partners LP 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Coastlands Capital GP LLC 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer
Coastlands Capital LLC 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer
Matthew D. Perry 10% 2,394,765 0 2,394,765 /s/ Matthew D. Perry Reporting Person
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .